Akèy › Atak kè › North Carolina › Raleigh
Etid klinik pou Atak kè nan Raleigh, NC
3 etid pou Atak kè ap chèche patisipan nan sit nan ak bò kote Raleigh (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Ap rekriteFaz 2/3
- North Carolina Nephrology, PA, Raleigh
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Ap rekriteFaz 3
- Accellacare US Inc, Raleigh
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
Ap rekriteFaz 3
- Duke Raleigh Hospital, Raleigh
Etid Atak kè nan lòt vil
- Rochester, MN6 etid
- Dallas, TX6 etid
- New York City, NY6 etid
- Boston, MA5 etid
- Detroit, MI4 etid
- Nashville, TN4 etid
- Knoxville, TN4 etid
- Houston, TX4 etid
- Hartford, CT4 etid
- Boca Raton, FL4 etid
- Los Angeles, CA4 etid
- Durham, NC3 etid
Lòt etid nan Raleigh
- Ensifizyans kadyak7 etid
- Dyabèt Tip 26 etid
- Obèsite6 etid
- Maladi atè koronè6 etid
- Degeneresans makile6 etid
- Akidan serebavaskilè5 etid
- Kansè Endomèt5 etid
- Sipwa5 etid
- Maladi kadyovaskilè5 etid
- Ateroskleroz5 etid
- Dyabèt4 etid
- Edem makile4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.